All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors could effectively reduce HbA(1C) and postprandial hyperglycemia and could incur only minimal danger of hypoglycemia. Patients with uncontrolled diabetes might be treated by the complementary action of insulin plus DPP-4 inhibitors. Here, we compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yen, Fu-Shun, Chiang, Jen-Huai, Hwu, Chii-Min, Yen, Yu-Hsin, Lin, Boniface J., Wei, James Cheng-Chung, Hsu, Chih-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321656/
https://www.ncbi.nlm.nih.gov/pubmed/30611254
http://dx.doi.org/10.1186/s12902-018-0330-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321656/
https://www.ncbi.nlm.nih.gov/pubmed/30611254
http://dx.doi.org/10.1186/s12902-018-0330-7

Ejemplares similares